508 related articles for article (PubMed ID: 15469385)
1. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells.
Dysart JS; Singh G; Patterson MS
Photochem Photobiol; 2005; 81(1):196-205. PubMed ID: 15469385
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Dysart JS; Patterson MS
Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
[TBL] [Abstract][Full Text] [Related]
3. Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells.
Dysart JS; Patterson MS; Farrell TJ; Singh G
Photochem Photobiol; 2002 Mar; 75(3):289-95. PubMed ID: 11950095
[TBL] [Abstract][Full Text] [Related]
4. Monitoring interstitial m-THPC-PDT in vivo using fluorescence and reflectance spectroscopy.
Kruijt B; van der Ploeg-van den Heuvel A; de Bruijn HS; Sterenborg HJ; Amelink A; Robinson DJ
Lasers Surg Med; 2009 Nov; 41(9):653-64. PubMed ID: 19802884
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic properties of meta-tetra(hydroxyphenyl)chlorin in human tumor cells.
Melnikova VO; Bezdetnaya LN; Potapenko AY; Guillemin F
Radiat Res; 1999 Oct; 152(4):428-35. PubMed ID: 10477920
[TBL] [Abstract][Full Text] [Related]
6. Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin.
Mitra S; Foster TH
Photochem Photobiol; 2005; 81(4):849-59. PubMed ID: 15807635
[TBL] [Abstract][Full Text] [Related]
7. Simple photodynamic therapy dose models fail to predict the survival of MLL cells after HPPH-PDT in vitro.
Weston MA; Patterson MS
Photochem Photobiol; 2009; 85(3):750-9. PubMed ID: 19140895
[TBL] [Abstract][Full Text] [Related]
8. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
9. Influence of incubation time and sensitizer localization on meta-tetra(hydroxyphenyl)chlorin (mTHPC)-induced photoinactivation of cells.
Sasnouski S; Pic E; Dumas D; Zorin V; D'Hallewin MA; Guillemin F; Bezdetnaya L
Radiat Res; 2007 Aug; 168(2):209-17. PubMed ID: 17638401
[TBL] [Abstract][Full Text] [Related]
10. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
11. Effects of fluence rate on cell survival and photobleaching in meta-tetra-(hydroxyphenyl)chlorin-photosensitized Colo 26 multicell tumor spheroids.
Coutier S; Mitra S; Bezdetnaya LN; Parache RM; Georgakoudi I; Foster TH; Guillemin F
Photochem Photobiol; 2001 Mar; 73(3):297-303. PubMed ID: 11281027
[TBL] [Abstract][Full Text] [Related]
12. Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.
Weston MA; Patterson MS
Photochem Photobiol; 2011; 87(5):1129-37. PubMed ID: 21575000
[TBL] [Abstract][Full Text] [Related]
13. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
Liu B; Farrell TJ; Patterson MS
Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic mechanisms induced by a combination of hypericin and a chlorin based-photosensitizer in head and neck squamous cell carcinoma cells.
Gyenge EB; Lüscher D; Forny P; Antoniol M; Geisberger G; Walt H; Patzke G; Maake C
Photochem Photobiol; 2013; 89(1):150-62. PubMed ID: 22882495
[TBL] [Abstract][Full Text] [Related]
15. Comparative sensitivity of microvascular endothelial cells, fibroblasts and tumor cells after in vitro photodynamic therapy with meso-tetra-hydroxyphenyl-chlorin.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2004; 80(2):236-41. PubMed ID: 15362947
[TBL] [Abstract][Full Text] [Related]
16. The influence of oxygen depletion and photosensitizer triplet-state dynamics during photodynamic therapy on accurate singlet oxygen luminescence monitoring and analysis of treatment dose response.
Jarvi MT; Niedre MJ; Patterson MS; Wilson BC
Photochem Photobiol; 2011; 87(1):223-34. PubMed ID: 21143603
[TBL] [Abstract][Full Text] [Related]
17. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA
Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792
[TBL] [Abstract][Full Text] [Related]
18. The cellular uptake of meta-tetra(hydroxyphenyl)chlorin entrapped in organically modified silica nanoparticles is mediated by serum proteins.
Compagnin C; Baù L; Mognato M; Celotti L; Miotto G; Arduini M; Moret F; Fede C; Selvestrel F; Rio Echevarria IM; Mancin F; Reddi E
Nanotechnology; 2009 Aug; 20(34):345101. PubMed ID: 19652275
[TBL] [Abstract][Full Text] [Related]
19. Predictions of mathematical models of tissue oxygenation and generation of singlet oxygen during photodynamic therapy.
Yuan J; Mahama-Relue PA; Fournier RL; Hampton JA
Radiat Res; 1997 Oct; 148(4):386-94. PubMed ID: 9339955
[TBL] [Abstract][Full Text] [Related]
20. Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity.
Coutier S; Bezdetnaya L; Marchal S; Melnikova V; Belitchenko I; Merlin JL; Guillemin F
Br J Cancer; 1999 Sep; 81(1):37-42. PubMed ID: 10487610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
